PD
Therapeutic Areas
Cycuria Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lymphotoxin-alpha-based therapy | Acute Myeloid Leukemia (AML) | Pre-clinical |
Leadership Team at Cycuria Therapeutics
DN
Dr. Nisit Khandelwal
Co-Founder & CEO
JH
John Haurum
Corporate Advisor
PD
Prof. Dr. Felix Wieland
Scientific Advisor